Advances in Nanoparticle-Based Therapeutics: From Extracellular Vesicles to Metal Nanocarriers for Cancer Therapy
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Nanomedicine and Nanotechnology".
Deadline for manuscript submissions: 31 December 2025 | Viewed by 13
Special Issue Editor
Interests: metal complexes; metallic nanoparticles, hybrid nanoparticles; hyperthermia; bioinorganic chemistry; phototherapy
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Cancer remains one of the most complex and aggressive diseases of our time, demanding smarter, more targeted therapeutic strategies. Over the past decade, two distinct yet increasingly converging fields—extracellular vesicle (EV) biology and metal-based nanotechnology—have opened new frontiers in cancer therapy.
Extracellular vesicles, the body’s natural messengers, have emerged as potent vehicles for drug delivery, capable of transporting therapeutic molecules with high specificity and low immunogenicity. At the same time, engineered metal-based nanocarriers, including gold, silver, and iron oxide nanoparticles, offer tunable platforms with precise control over drug release, imaging, and multifunctional targeting.
This Special Issue explores the dynamic interface between these two approaches. It brings together cutting-edge research that spans from fundamental insights into EV biogenesis and engineering, to the design and functionalization of metal nanocarriers. The goal is to harness the best of both biological precision and material innovation to overcome current limitations in cancer treatment.
By highlighting key advances, challenges, and translational perspectives, this Special Issue aims to spark deeper collaboration across disciplines and drive forward the next generation of smart cancer therapeutics.
Dr. Eleni K. Efthimiadou
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- nanoparticle
- extracellular vesicle
- metal-based nanotechnology
- drug delivery
- cancer
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
